Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Spinal Mobilization With Arm Movement and Kaltenborn Mobilization in Adhesive Capsulitis (SMWAM)

23 juli 2026 uppdaterad av: Riphah International University

Effects of Spinal Mobilization With Arm Movement and Kaltenborn Mobilization on Pain, Range of Motion, Functional Reaching, and Disability in Adhesive Capsulitis

To compare the effects of spinal mobilization with arm movement and Kaltenborn Mobilization on pain, range of motion, functional reaching, and disability in patients with Adhesive Capsulitis.

Studieöversikt

Detaljerad beskrivning

A randomized clinical trial compared the effectiveness of Kaltenborn mobilization and muscle energy techniques in individuals with adhesive capsulitis. Seventy-six participants were randomly allocated into two treatment groups. Pain, shoulder range of motion, and disability were assessed using the Numeric Pain Rating Scale (NPRS), goniometry, and the Shoulder Pain and Disability Index (SPADI) at baseline and after four weeks of treatment. The findings demonstrated that Kaltenborn mobilization produced greater improvements in pain reduction, shoulder range of motion, and functional ability.

A quasi-experimental study evaluated the effects of Kaltenborn mobilization and muscle energy techniques in patients with chronic adhesive capsulitis. Participants received their respective manual therapy interventions in combination with conventional rehabilitation. Shoulder external rotation, shoulder abduction, pain intensity, and functional disability were assessed before and after treatment. The results indicated that Kaltenborn mobilization was more effective than muscle energy techniques in improving shoulder mobility, reducing pain, and enhancing functional outcomes.

A randomized controlled trial compared muscle energy techniques with Kaltenborn mobilization for improving shoulder range of motion in individuals with adhesive capsulitis. Outcomes were assessed at baseline and during follow-up using goniometric measurements. The findings showed that muscle energy techniques produced greater improvements in shoulder flexion and abduction, whereas rotational movements demonstrated no clear advantage over Kaltenborn mobilization.

A randomized clinical trial investigated the effects of Spinal Mobilization with Arm Movement (SMWAM) compared with the Maitland mobilization technique on shoulder function. Pain, shoulder range of motion, and muscle activity were evaluated before and after treatment. The results demonstrated that spinal mobilization with arm movement effectively reduced pain, normalized shoulder muscle activity, and increased shoulder range of motion.

A randomized controlled trial compared the effects of anterior and posterior Grade III Kaltenborn glides on shoulder function in patients with adhesive capsulitis. External rotation and functional ability were evaluated using goniometric measurements and the Shoulder Pain and Disability Index (SPADI). The findings indicated that posterior gliding mobilization resulted in greater improvements in external rotation and shoulder function than anterior gliding.

A randomized controlled trial examined the immediate effects of Spinal Mobilization with Arm Movement (SMWAM) on shoulder performance. The intervention involved cervical spinal mobilization combined with repeated active arm abduction. The study reported immediate improvements in shoulder movement and suggested that SMWAM enhances shoulder function by correcting cervical spinal alignment and stimulating joint mechanoreceptors.

Although both Spinal Mobilization with Arm Movement (SMWAM) and Kaltenborn Mobilization have demonstrated beneficial effects in reducing pain and improving shoulder mobility, existing evidence has primarily evaluated these techniques independently or compared them with other manual therapy approaches. Direct comparative evidence between SMWAM and Kaltenborn Mobilization in individuals with adhesive capsulitis remains limited, particularly regarding their effects on pain, range of motion, functional reaching, and disability. Therefore, further comparative research is warranted to determine the more effective intervention for optimizing functional recovery in patients with adhesive capsulitis.

Studietyp

Interventionell

Inskrivning (Beräknad)

50

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
      • Lahore, Punjab Province, Pakistan, 54000
        • Rekrytering
        • Alfalah Medical Center
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  • Age 35-50 years
  • Both male and female genders
  • Pain rating 3 to 7 on NPRS for at least 3 months
  • Idiopathic frozen shoulder
  • Stage II and III frozen shoulder
  • Positive Apley's Scratch test
  • Unilateral frozen shoulder
  • Frozen shoulder with at least 25% restricted ROM
  • Presence of global restriction in passive range of motion (PROM) in a capsular pattern (ER > ABD > IR)

Exclusion Criteria:

  • Arthritic shoulder
  • Rotator cuff disease
  • Post-traumatic stiff shoulder
  • Post-CABG shoulder-hand syndrome
  • Post-stroke frozen shoulder
  • Bilateral frozen shoulder
  • Complex Regional Pain Syndrome
  • Any fracture or other injury
  • Any systemic illness
  • Any inflammatory disease (Rheumatoid arthritis, gout)
  • Any neurological disease
  • Frozen Shoulder secondary to Brachial Plexus Injury, Parkinsonism, Ankylosis, Infection, or Arthroplasty
  • Tendon calcification

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Spinal Mobilization with Arm Movement
Participants will be seated upright while the therapist applies a sustained transverse glide to the C4 spinous process toward the side opposite the affected shoulder. The glide will be maintained as the participant actively abducts the affected arm to the pain-free or maximum tolerated range and returns to the starting position. The technique will be performed for 10 repetitions per session, ensuring controlled movement, proper posture, and patient comfort throughout the intervention.
Intervention: Spinal Mobilization with Arm Movement (SMWAM) Position: Participant seated upright with neutral spine and head posture Technique: Sustained transverse glide applied to the C4 spinous process toward the side opposite the affected shoulder during active shoulder abduction Movement: Active shoulder abduction to the pain-free or maximum tolerated range, followed by return to the starting position while maintaining the glide Dosage: 10 repetitions per session Purpose: To reduce pain, improve shoulder mobility, and enhance functional movement.
Andra namn:
  • SMWAM
Experimentell: Kaltenborn Mobilization
Following the application of a moist hot pack, participants will receive Kaltenborn Grade I glenohumeral traction followed by Grade III ventral glide and Grade III caudal glide in the same treatment session. Each mobilization will be performed for 15 repetitions, with a 30-second sustained hold and 10-second rest between repetitions, for a total treatment time of approximately 10 minutes. The techniques will be applied in standardized patient positions with appropriate scapular stabilization to improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.
Intervention: Kaltenborn Mobilization Technique (KMT) Pre-treatment: Moist hot pack application Techniques: Grade I glenohumeral traction, Grade III ventral glide, and Grade III caudal glide Dosage: 15 repetitions of each technique with a 30-second hold and 10-second rest between repetitions Duration: Approximately 10 minutes per session Purpose: To improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.
Andra namn:
  • KMT

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Pain by Numeric Pain Rating Scale (NPRS)
Tidsram: 6 weeks
The Numeric Pain Rating Scale (NPRS) is an 11-point self-reported scale (0 = no pain, 10 = worst imaginable pain) used to assess pain intensity in clinical and research settings.
6 weeks
Range of Motion (External Rotation, Abduction, Internal Rotation)
Tidsram: 6 weeks
A goniometer is a standard clinical instrument used to measure joint range of motion (ROM)
6 weeks
Functional Disability
Tidsram: 6 weeks
The Shoulder Pain and Disability Index (SPADI) is a 13-item self-administered questionnaire used to assess shoulder pain and functional disability.
6 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Annum Manzoor, MS OMPT, Riphah International University

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 juli 2026

Primärt slutförande (Beräknad)

1 augusti 2026

Avslutad studie (Beräknad)

1 september 2026

Studieregistreringsdatum

Först inskickad

21 juli 2026

Först inskickad som uppfyllde QC-kriterierna

23 juli 2026

Första postat (Faktisk)

24 juli 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

24 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

23 juli 2026

Senast verifierad

1 juli 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera